Trump sparks debate, expected to announce that paracetamol use during pregnancy increases risk of autism in children

2025-09-22 18:17:57Lifestyle SHKRUAR NGA REDAKSIA VOX
Trump sparks debate, expected to announce that paracetamol use during pregnancy
Trump and Kennedy Jr.

The US administration, led by Donald Trump, is preparing to officially announce the discovery of a possible link between the use of paracetamol during pregnancy and an increased risk of autism spectrum disorders in children. This is revealed by the Washington Post, after the US president himself made reference to a major announcement on the subject, scheduled for today, Monday, September 22: “We are going to make a major announcement on autism ,” Trump said during his speech at Charlie Kirk’s funeral.

According to sources close to the executive branch, the statement will be issued by the Department of Health and Human Services, currently headed by Robert F. Kennedy Jr., and will be accompanied by an information campaign aimed at women of childbearing age. The news has raised concerns among medical experts and scientific organizations, which are calling for caution in the absence of conclusive evidence. Paracetamol, known in the United States under the trade name Tylenol, is currently considered safe for use during pregnancy by most international health authorities, as long as it is taken in recommended doses.

Autism and paracetamol, a controversial scientific hypothesis

The announcement is based on an internal review of several studies conducted in recent years, which would suggest a possible increased risk of autism diagnosis in children who were exposed to paracetamol during pregnancy. However, this research does not establish a direct cause-and-effect relationship and many academic institutions continue to consider the available evidence to be insufficient.

What has attracted even more attention is the statement with which Trump announced the initiative: "We have found an answer to autism," he said in front of 200,000 supporters of the MAGA movement, gathered to commemorate activist Charlie Kirk, killed by a sniper at the University of Utah, describing the announcement as "one of the most important things we will do ."

These words have revived public debate on a topic marked for years by scientific controversy and politically sensitive positions.

Autism treatment and folic acid testing

At the same time, the administration plans to promote clinical trials of Leucovorin — a synthetic form of folic acid — as a potential treatment for some symptoms of autism. The substance, currently approved for oncology and neurological uses, has shown improvements in language skills and social understanding in children in some small initial trials.

Even here, the scientific community is urging caution. The studies mentioned have not yet been peer-reviewed and large-scale data are lacking to confirm effectiveness and safety. The fear from the medical world is that such initiatives, if communicated hastily, could create false hopes or lead to inappropriate health behaviors.

The number of people with autism in the U.S. is on the rise. About 1 in every 31 children will be diagnosed with autism by age 8 in 2022, up from 1 in 36 in 2020, according to a report by the U.S. Centers for Disease Control and Prevention released in April.

There are two main reasons for the increase, according to doctors. The first is that the definition of autism was expanded by the psychiatric community in 2013, so more people now qualify for an autism diagnosis.

Second, there has been a push for better screening of children, especially infants, for signs of autism.

This push to increase awareness of the symptoms has been accompanied by greater acceptance of the disorder, so people are less afraid to seek help or identify as having autism.


Video